Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Pathology ; (12): 10-14, 2013.
Artigo em Chinês | WPRIM | ID: wpr-256267

RESUMO

<p><b>OBJECTIVE</b>To study the possible clonal origin of neuroendocrine cells in colorectal adenocarcinoma.</p><p><b>METHODS</b>Twenty-six microsatellite loci were screened using laser capture microdissection, DNA extraction and whole genome amplification. Microsatellite instability (MSI) and loss of heterozygosity (LOH) in adenocarcinoma cells and neuroendocrine cells amongst 30 cases of colorectal carcinoma with neuroendocrine differentiation were detected using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP)-silver staining. The mutation status of p53 was evaluated by PCR-sequencing. The clonal origin of neuroendocrine cells in colorectal adenocarcinoma was determined.</p><p><b>RESULTS</b>Amongst the 30 cases studied, the prevalence of MSI was 16.9% while that of LOH was 8.5%. The rate showed no statistically significant difference between adenocarcinoma cells and neuroendocrine cells. In 6 cases, the microsatellite alteration was entirely consistent. In 23 cases, the rate of microsatellite alteration consistency was greater than that of inconsistency. In 1 case, the consistency and inconsistency rates were identical. There was statistically significant difference between consistency and inconsistency of microsatellite alteration. The prevalence of p53 mutation was 16.7% which was the same for both adenocarcinoma cells and neuroendocrine cells.</p><p><b>CONCLUSIONS</b>Adenocarcinoma cells and neuroendocrine cells in colorectal adenocarcinoma with neuroendocrine differentiation have similar biologic changes. It is likely that they are of identical origin.</p>


Assuntos
Humanos , Adenocarcinoma , Genética , Patologia , Neoplasias Colorretais , Genética , Patologia , Análise Mutacional de DNA , Microdissecção e Captura a Laser , Perda de Heterozigosidade , Instabilidade de Microssatélites , Células Neuroendócrinas , Patologia , Proteína Supressora de Tumor p53 , Genética
2.
Chinese Journal of Medical Genetics ; (6): 288-292, 2009.
Artigo em Chinês | WPRIM | ID: wpr-287406

RESUMO

<p><b>OBJECTIVE</b>To study the expression of Galectin-3 and CDC25B mRNA in gastric carcinoma and their correlation with clinical-pathological features and the survival time.</p><p><b>METHODS</b>Tissue microarray (TMA) technique and in situ hybridization were used to detect the expression of Galectin-3 and CDC25B mRNA in 220 gastric carcinoma specimens and 31 normal gastric mucosa samples.</p><p><b>RESULTS</b>In situ hybridization results revealed that from the 220 cases, the positive expression rate of Galectin-3 and CDC25B mRNA were 58.6% and 54.1%, respectively. There was significant relationship between the Galectin-3 mRNA expression and tumor diameter, advanced TNM stage, invasion depth, vessel invasion, lymph node and distant metastasis. There was significant relationship between CDC25B mRNA expression and tumor diameter, advanced TNM stage, vessel invasion, lymph node and distant metastasis. In addition, there was apositive relationship of Galectin-3 and CDC25B mRNA expression. Finally, the mean survival time in cases with Galectin-3 and CDC25B mRNA positive expression was significantly shorter than those without Galectin-3 and CDC25B expression.</p><p><b>CONCLUSION</b>The expression of Galectin-3 and CDC25B mRNA appears to act as a promoting factor in the onset and development of gastric cancer. It can be used as a marker of prognosis of gastric carcinoma in clinical practice.</p>


Assuntos
Feminino , Humanos , Masculino , Galectina 3 , Genética , Metabolismo , Expressão Gênica , Genética , Regulação Neoplásica da Expressão Gênica , Prognóstico , RNA Mensageiro , Metabolismo , Neoplasias Gástricas , Genética , Metabolismo , Patologia , Fosfatases cdc25 , Genética , Metabolismo
3.
Chinese Journal of Oncology ; (12): 515-519, 2009.
Artigo em Chinês | WPRIM | ID: wpr-293077

RESUMO

<p><b>OBJECTIVE</b>To investigate the expression of CD147 and E-cadherin in gastric carcinoma and their correlation with clinicopathological features.</p><p><b>METHODS</b>The expression of CD147 and E-cadherin in gastric cancer tissue chip (TC) was detected by in situ hybridization (ISH) and immunohistochemistry in 220 cases of gastric carcinoma and 31 cases with normal gastric mucosa.</p><p><b>RESULTS</b>The expression rates of CD147 mRNA, E-cadherin mRNA and E-cadherin protein were 50.5%, 17.7% and 15.5%, respectively. The CD147 expression was negatively correlated with E-cadherin expression. There was a significant relationship between CD147 mRNA expression and tumor diameter, TNM stage, invasion depth, vessel invasion, lymph node and distant metastasis. The E-cadherin mRNA expression was closely related with TNM stage, invasion depth and vascular invasion. There was a significant relationship between E-cadherin protein expression and tumor diameter, TNM stage and vascular invasion. The mean survival time in cases with CD147-positive expression was shorter than that in negative cases, while E-cadherin was in an opposite relationship.</p><p><b>CONCLUSION</b>In gastric carcinoma, up-regulation of CD147 and down-regulation of E-cadherin are in a negative correlation. The examination of both these two factors together is useful for predicting the invasion and metastasis of gastric cancer, therefore, can be used as a significant marker to direct clinic therapy and estimation of prognosis.</p>


Assuntos
Humanos , Adenocarcinoma , Metabolismo , Patologia , Adenocarcinoma Mucinoso , Metabolismo , Patologia , Adenocarcinoma Papilar , Metabolismo , Patologia , Basigina , Genética , Metabolismo , Biomarcadores Tumorais , Metabolismo , Caderinas , Genética , Metabolismo , Carcinoma de Células em Anel de Sinete , Metabolismo , Patologia , Regulação Neoplásica da Expressão Gênica , Metástase Linfática , Invasividade Neoplásica , Estadiamento de Neoplasias , RNA Mensageiro , Metabolismo , Neoplasias Gástricas , Metabolismo , Patologia , Taxa de Sobrevida , Carga Tumoral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA